Sword Bio

About

Sword Bio is a bioanalytical contract research organization (CRO) based in Chicago, Illinois, founded in 2004. The company specializes in assay development, validation, and bioanalytical services for pharmaceutical and biotech clients, focusing on preclinical and clinical trial support. With a total funding of $8.29 million, Sword Bio operates as a privately held company and has expanded its quality systems to meet regulatory standards for clinical trials. The services offered by Sword Bio include immunogenicity testing, pharmacokinetic analysis, and biomarker services. The company emphasizes compliance with GLP, GCP, and GCLP standards. Sword Bio also utilizes proprietary resonance Raman technology to enable high-sensitivity assays for challenging biomarkers. The leadership team includes experienced professionals who drive operational and commercial growth, contributing to a significant increase in revenue in recent years. Sword Bio is recognized for its personalized service, speed in project initiation, and expertise in complex assays.